CORTEXA
← Browse
openalexFrontiers in Pharmacology2026-07-24Cited by 0

GPR55 and PINK1 as emerging therapeutic targets in Glioma: insights into their modulation by phytochemicals and plant extracts

Andrés David Turizo Smith, Jean Carlos Martinez Perez, Juan Camilo Marín Loaiza, Gonzalo Arboleda

The expression of certain genes and proteins in brain tumors, particularly gliomas, presents potential therapeutic targets and biomarkers. One of such genes encodes the protein PINK1 (PTEN-induced Kinase 1), which has been primarily studied due to its mutations being linked to Parkinson’s disease (PD). Additionally, epidemiological studies have observed a reduced risk of developing certain types of cancer in patients with neurodegenerative diseases and vice versa. The GPR55 receptor (G protein-coupled receptor 55) exhibits pro-oncogenic properties, and its expression correlates with tumor aggressiveness and the activation of the MAPK/ERK signaling pathway. This review would aim to provide an overview of the current understanding of the relationship between PINK1 and GPR55 proteins in glioma pathophysiology and explore the potential use of plant extracts as a therapeutic alternative to regulate their expression.

View free PDFSource page

Related papers

openalexFrontiers in Pharmacology2026-07-24

Editorial: Increasing importance of patients-generated real world data for healthcare policy decisions about medicinal products: volume III

Wai Yee Choon, K C Lee, Paul Scuffham, Shu Chuen Li, David Bin-Chia Wu, Jeff J. Guo

Increasing importance of patient-generated real-world data for healthcare policy decisions about medicinal products: Volume III Real-world data (RWD) and the real-world evidence (RWE) derived from it have moved from the margins to the centre of decision-making about medicinal pro…

View free PDFSource page
openalexFrontiers in Pharmacology2026-07-24

Editorial: Exploring the interplay between stress, neuropeptides, and alcohol use disorder

Kabirullah Lutfy, Marcelo López

Alcohol use disorders (AUD) are major public health issues, with a significant negative impact on the health system and the economy. Unfortunately, only a handful of pharmacotherapeutic agents are available to treat patients with AUD. Notably, these medications have limited effic…

View free PDFSource page
openalexFrontiers in Pharmacology2026-07-24

Protective effects and possible mechanisms of matrine-type alkaloids (matrine and oxymatrine) in animal models of ulcerative colitis: a preclinical systematic review and meta-analysis

吕书晴, H W Yang, Shiying Wang, Jiahui Ye, S H. M. Huang, Linkun Cai

Background Matrine and oxymatrine are bioactive alkaloids from Sophora species with reported anti-inflammatory and antioxidant effects in ulcerative colitis (UC). However, their overall efficacy has not been systematically evaluated. Methods Databases including PubMed, EMBASE, We…

View free PDFSource page
openalexFrontiers in Pharmacology2026-07-24

Indobufen-based dual antiplatelet therapy in patients undergoing PCI: a systematic review and meta-analysis

Yiheng Liu, B Y Liu, Weiran Dai

Background Conventional dual antiplatelet therapy (DAPT) post percutaneous coronary intervention (PCI) comprises aspirin and a P2Y 12 inhibitor. However, aspirin increases gastrointestinal and bleeding risks. Indobufen, a reversible COX-1 inhibitor, may offer a safer alternative.…

View free PDFSource page
openalexFrontiers in Pharmacology2026-07-23

Immunomodulatory properties of venom-derived crotamine

Isadora Oliveira, I M P L V O Ferreira, Lorena Sousa, João Alberghini-dos-Santos, Felipe Cerni, Manuela Pucca

Crotamine is a low-molecular-weight cationic polypeptide isolated from Crotalus durissus terrificus snake venom, classified as a non-enzymatic toxin with distinctive structural and functional properties. This toxin also exhibits characteristics of a cell-penetrating peptide, owin…

View free PDFSource page
openalexFrontiers in Pharmacology2026-07-23

Severity-stratified vasopressor-escalation strategies in septic shock: a cross-fitted doubly robust analysis with external replication

Yuhang Zhang, Menglin Han, Xiaosu Liu, Guanyu Chen, Li Zhang

Background The optimal vasopressor-escalation strategy after norepinephrine in septic shock remains uncertain, with randomized trials showing no clear winner and observational data suggesting severity-dependent effects. We characterized severity-stratified heterogeneity for addin…

View free PDFSource page